Long-Acting GHRH Analogue

CJC-1295 with DAC Australia

Everything researchers need to know about CJC-1295 with DAC — mechanism, published dosing protocols, side effect profiles, reconstitution, and how to source third-party tested CJC-1295 with DAC in Australia.

Shop CJC-1295 with DAC — From $59.00 Dosage guide

Quick facts

Also known as: Drug Affinity Complex Modified GRF
Form: Lyophilised powder (>99% purity)
Variants: 2 mg, 5 mg
🇦🇺 3–5 business days

HPLC/MS VerifiedCOA DocumentedAU Same-Day DispatchPayID AcceptedHPLC/MS VerifiedCOA DocumentedAU Same-Day DispatchPayID AcceptedHPLC/MS VerifiedCOA DocumentedAU Same-Day DispatchPayID Accepted

Overview

What Is CJC-1295 with DAC?

CJC-1295 with DAC (Drug Affinity Complex) is a modified growth hormone-releasing hormone analogue with an extended half-life due to its DAC modification, which enables covalent binding to serum albumin. This results in sustained GH elevation over days rather than hours, making it suitable for long-duration research protocols.

Also known as Drug Affinity Complex Modified GRF, CJC-1295 with DAC is supplied as a lyophilised research peptide for laboratory use only. The DAC modification extends the half-life to approximately 6-8 days, compared to 30 minutes for native GHRH. Studies show sustained elevation of GH and IGF-1 levels with less frequent administration. Research indicates a more tonic (rather than pulsatile) GH release pattern compared to non-DAC variants.

View CJC-1295 with DAC Products

Mechanism

How CJC-1295 with DAC Works — Research Mechanism

The DAC modification extends the half-life to approximately 6-8 days, compared to 30 minutes for native GHRH. Studies show sustained elevation of GH and IGF-1 levels with less frequent administration. Research indicates a more tonic (rather than pulsatile) GH release pattern compared to non-DAC variants.

Drug Affinity Complex (DAC) enables covalent albumin binding
Extended half-life of approximately 6–8 days
Sustained GH and IGF-1 elevation over days vs hours
Tonic rather than pulsatile GH release pattern
Modified GRF 1-29 base structure with DAC modification

Research reference

CJC-1295 with DAC Dosage — Published Research Protocols

The following reference points are drawn from published research literature. These figures are provided for research reference only and do not constitute dosing recommendations. CJC-1295 with DAC is sold strictly for laboratory research use.

Protocol tier	Published research detail
Research reference	Published literature varies by model and endpoint — consult primary sources for protocol-specific dosing in laboratory settings
Administration route	Subcutaneous injection is most common in published peptide research protocols
Frequency	Dosing frequency depends on compound half-life and research design — daily to weekly intervals reported in literature
Available vial sizes	2 mg, 5 mg — select based on your laboratory protocol requirements
Titration	Many research protocols start at lower doses and escalate to assess receptor response and tolerability in models

Research use only: FOR LABORATORY RESEARCH USE ONLY. Not for human consumption, injection, or therapeutic use. All products are sold strictly as research chemicals. By purchasing, you confirm you are 18+ and agree to use products solely for legitimate research purposes.

Order Research-Grade CJC-1295 with DAC — From $59.00

Safety research

CJC-1295 with DAC Side Effects — Research Findings

Side effect profiles documented in published CJC-1295 with DAC research depend on dose, route of administration, and model system. The following are commonly reported findings from research literature — not from personal use contexts.

Injection site erythema or discomfort in subcutaneous administration studies
Transient local inflammation reported in some tissue repair models
Generally well-tolerated in published preclinical research at standard doses
No significant systemic adverse events consistently reported across literature

Handling

Reconstituting CJC-1295 with DAC

CJC-1295 with DAC is supplied as a lyophilised powder and must be reconstituted before use in laboratory protocols. Use bacteriostatic water (0.9% benzyl alcohol) for multi-dose vials. Inject diluent slowly down the inside wall of the vial — do not shake vigorously.

Bacteriostatic water is available from EvoPeak. Store reconstituted peptide at 2–8°C and lyophilised powder at −20°C.

Shop bacteriostatic water

Australia

How to Get CJC-1295 with DAC in Australia

Researchers in Australia can source CJC-1295 with DAC through EvoPeak — a local supplier offering third-party tested research compounds with batch-specific COA documentation and domestic shipping.

1
Browse CJC-1295 with DAC variants (2 mg, 5 mg) on the EvoPeak product page
2
Review the certificate of analysis (COA) for HPLC purity and mass spectrometry identity verification
3
Select your vial size and add to cart — prices include GST with same-day Australian dispatch
4
Receive your order with batch-specific quality documentation for laboratory traceability

Buy CJC-1295 with DAC — Shipped from Australia — From $59.00

Quality Standard

Research compounds need evidence, not guesswork.

Every shopping path leads back to the same core standard: research-use positioning, third-party quality signals, transparent documentation, and careful handling guidance.

HPLC/MS verified

Purity and identity checks support confident compound selection for controlled research.

Endotoxin screened

Quality review extends beyond purity so researchers can evaluate handling risk.

Batch documentation

COA-first product pages keep quality signals close to every purchase decision.

Australia shipped

Local fulfilment keeps delivery predictable for Australian research customers.

FAQ

CJC-1295 with DAC — Common Questions

What is CJC-1295 with DAC?

Long-acting GHRH analogue for sustained GH elevation research. CJC-1295 with DAC (Drug Affinity Complex) is a modified growth hormone-releasing hormone analogue with an extended half-life due to its DAC modification, which enables covalent binding to serum albumi… It is supplied for laboratory research use only.

What is the CJC-1295 with DAC dosage used in research?

Published research uses varying doses depending on the model and endpoint. EvoPeak supplies 2 mg and 5 mg vials. All dosage information is for research reference only and does not constitute recommendations.

What are the side effects of CJC-1295 with DAC?

Side effect profiles in published research depend on dose, route, and model system. Consult primary literature for compound-specific findings. All information is drawn from research contexts, not personal use.

Can I buy CJC-1295 with DAC in Australia?

Yes. EvoPeak supplies research-grade CJC-1295 with DAC to Australian researchers with HPLC/MS verification, batch-specific COA documentation, and domestic shipping. Products are for laboratory research use only.

How do I get CJC-1295 with DAC in Australia?

Order from the EvoPeak shop page, select your vial size, review the COA, and checkout with local Australian fulfilment.

How do I reconstitute CJC-1295 with DAC?

CJC-1295 with DAC is supplied as lyophilised powder. Reconstitute with bacteriostatic water, inject diluent slowly down the vial wall without shaking, and store at 2–8°C once reconstituted. Bacteriostatic water is available from EvoPeak.

What purity standard does EvoPeak CJC-1295 with DAC meet?

Every batch undergoes HPLC purity analysis (targeting >99%), mass spectrometry identity verification, and endotoxin screening. Batch-specific COAs are available on the product page.